Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
007630.KS Stock Summary
In the News
007630.KS Financial details
Company Rating
-
Market Cap
0
Income
-2.2B
Revenue
1.31B
Book val./share
1571.86
Cash/share
1.53
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.42
Forward P/E
-
PEG
0.05
P/S
-
P/B
0.03
P/C
29.41
P/FCF
-
Quick Ratio
-
Current Ratio
0.13
Debt / Equity
1.16
LT Debt / Equity
-
-
-
EPS (TTM)
-55.16
EPS next Y
-
EPS next Q
-
EPS this Y
-68.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-38.78%
Revenue last 5Y
-26.25%
Revenue Q/Q
-
EPS Q/Q
68.98%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-7%
ROC
-0.04%
Gross Margin
10%
Oper. Margin
-36%
Profit Margin
-67%
Payout
-
Shs Outstand
44.99M
Shs Float
41.86M
-
-
-
-
Target Price
-
52W Range
30-50
52W High
-10%
52W Low
+50%
RSI
-
Rel Volume
-
Avg Volume
-
Volume
8.83M
Perf Week
0%
Perf Month
0%
Perf Quarter
0%
Perf Half Y
-96.33%
-
-
-
-
Beta
1.03135
-
-
Volatility
0%, 0%
Prev Close
0%
Price
45
Change
-
007630.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2020-12-31
Metric | History | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.16K | 1.65K | 325.5 | 247.93 | 162.54 | |
Net income per share | -1.26K | -164.85 | -779.99 | -346.57 | -108.34 | |
Operating cash flow per share | -259.13 | -741.7 | -486.96 | -73.14 | -234.62 | |
Free cash flow per share | -285.92 | -769.68 | -541.38 | -73.2 | -234.62 | |
Cash per share | 1.04K | 202.22 | 104.63 | 246.74 | 5.2 | |
Book value per share | 829.67 | 1.18K | 1.24K | 1.55K | 1.59K | |
Tangible book value per share | 795.45 | 1.14K | 1.19K | 1.52K | 1.59K | |
Share holders equity per share | 829.67 | 1.18K | 1.24K | 1.55K | 1.59K | |
Interest debt per share | 1.62K | 1.11K | 4.34K | 2.25K | 1.87K | |
Market cap | 623.12M | 810.27M | 1.41B | 1.72B | 1.8B | |
Enterprise value | 7.49B | 17.55B | 112.93B | 72.91B | 75.08B | |
P/E ratio | -0.04 | -0.27 | -0.06 | -0.13 | -0.42 | |
Price to sales ratio | 0.02 | 0.03 | 0.14 | 0.18 | 0.28 | |
POCF ratio | -0.17 | -0.06 | -0.09 | -0.62 | -0.19 | |
PFCF ratio | -0.16 | -0.06 | -0.08 | -0.61 | -0.19 | |
P/B Ratio | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | |
PTB ratio | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | |
EV to sales | 0.25 | 0.59 | 11.11 | 7.69 | 11.52 | |
Enterprise value over EBITDA | -0.59 | -11.08 | -52.18 | -12.02 | -33.45 | |
EV to operating cash flow | -2.09 | -1.31 | -7.43 | -26.05 | -7.98 | |
EV to free cash flow | -1.89 | -1.27 | -6.68 | -26.03 | -7.98 | |
Earnings yield | -28 | -3.66 | -17.33 | -7.7 | -2.41 | |
Free cash flow yield | -6.35 | -17.1 | -12.03 | -1.63 | -5.21 | |
Debt to equity | 1.85 | 0.89 | 2.94 | 1.35 | 1.16 | |
Debt to assets | 0.36 | 0.35 | 0.69 | 0.53 | 0.5 | |
Net debt to EBITDA | -0.54 | -10.57 | -51.53 | -11.73 | -32.65 | |
Current ratio | 0.51 | 0.28 | 0.05 | 0.13 | 0.13 | |
Interest coverage | -4.42 | -4.94 | -0.43 | -0.66 | -1.43 | |
Income quality | 0.21 | 4.5 | 0.62 | 0.21 | 2.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.09 | 0.04 | 0.02 | |
Research and developement to revenue | 0.02 | 0.02 | 0.03 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | 0.1 | 0.04 | 0.11 | 0 | 0 | |
Capex to revenue | -0.01 | -0.02 | -0.17 | 0 | 0 | |
Capex to depreciation | -0.39 | -1.41 | -2.67 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0.08 | 0 | 0 | |
Graham number | 4.85K | 2.1K | 4.67K | 3.48K | 1.97K | |
ROIC | -0.21 | -0.13 | -0.08 | -0.02 | -0.02 | |
Return on tangible assets | -0.3 | -0.05 | -0.15 | -0.09 | -0.03 | |
Graham Net | -2.4K | -1.65K | -3.91K | -2.15K | -2.1K | |
Working capital | -21.6B | -21.07B | -114.98B | -77.17B | -71.48B | |
Tangible asset value | 11.01B | 20.51B | 37.14B | 58.15B | 63.57B | |
Net current asset value | -25.94B | -25.43B | -119.51B | -80.32B | -74.08B | |
Invested capital | 1.85 | 0.89 | 2.94 | 1.35 | 1.16 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 15.76B | 12.56B | 3.54B | 75.45M | 41.76M | |
Average inventory | 2.99B | 623.27M | 482.06M | 351.35M | 88.62M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 235.22 | 89.97 | 2.68 | 3.51 | 0.03 | |
Days of inventory on hand | 11.02 | 5.11 | 22.38 | 5.76 | 2.52 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.55 | 4.06 | 136.21 | 104.06 | 14.17K | |
Inventory turnover | 33.13 | 71.48 | 16.31 | 63.32 | 144.62 | |
ROE | -1.52 | -0.14 | -0.63 | -0.22 | -0.07 | |
Capex per share | -26.79 | -27.97 | -54.41 | -0.06 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-06-30 for Q2
Metric | History | 2020-06-30 | 2020-09-30 | 2020-12-31 | 2021-03-31 | 2021-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 37.97 | 26.84 | 5.96 | 0.49 | 0 | |
Net income per share | -27.4 | -4.24 | -36.61 | -5.32 | -8.99 | |
Operating cash flow per share | -38.22 | -196.51 | -20.68 | -4.57 | -4.51 | |
Free cash flow per share | -38.22 | -196.51 | -20.68 | -4.57 | -4.51 | |
Cash per share | 241.75 | 47.86 | 5.3 | 0.66 | 1.53 | |
Book value per share | 1.45K | 1.45K | 1.62K | 1.41K | 1.57K | |
Tangible book value per share | 1.42K | 1.42K | 1.62K | 1.41K | 1.57K | |
Share holders equity per share | 1.45K | 1.45K | 1.62K | 1.41K | 1.57K | |
Interest debt per share | 2.08K | 2.08K | 1.87K | 1.62K | 1.82K | |
Market cap | 1.77B | 1.77B | 1.77B | 2.02B | 1.8B | |
Enterprise value | 75.19B | 83.12B | 75.05B | 75.05B | 74.68B | |
P/E ratio | -0.41 | -2.66 | -0.31 | -2.11 | -1.25 | |
Price to sales ratio | 1.19 | 1.68 | 7.55 | 91.33 | 0 | |
POCF ratio | -1.18 | -0.23 | -2.18 | -9.85 | -9.97 | |
PFCF ratio | -1.18 | -0.23 | -2.18 | -9.85 | -9.97 | |
P/B Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
PTB ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
EV to sales | 50.4 | 78.83 | 320.36 | 3.39K | 0 | |
Enterprise value over EBITDA | -70.72 | -462.2 | -64.77 | -365.28 | -207.12 | |
EV to operating cash flow | -50.06 | -10.77 | -92.38 | -365.1 | -412.69 | |
EV to free cash flow | -50.06 | -10.77 | -92.38 | -365.1 | -412.69 | |
Earnings yield | -0.61 | -0.09 | -0.81 | -0.12 | -0.2 | |
Free cash flow yield | -0.85 | -4.37 | -0.46 | -0.1 | -0.1 | |
Debt to equity | 1.43 | 1.44 | 1.16 | 1.15 | 1.16 | |
Debt to assets | 0.55 | 0.55 | 0.5 | 0.49 | 0.49 | |
Net debt to EBITDA | -69.06 | -452.37 | -63.24 | -355.43 | -202.12 | |
Current ratio | 0.12 | 0.12 | 0.13 | 0.13 | 0.13 | |
Interest coverage | 0 | 0 | 234.57 | 0 | 0 | |
Income quality | 1.4 | 46.39 | 0.56 | 0.86 | 0.5 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.54 | 0.4 | -0.3 | 0.58 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 946.19 | 371.37 | 1.15K | 410.65 | 563.98 | |
ROIC | -0.01 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.01 | 0 | -0.01 | 0 | 0 | |
Graham Net | -2.11K | -2.31K | -2.15K | -1.88K | -2.11K | |
Working capital | -79.61B | -79.45B | -71.48B | -71.68B | -71.83B | |
Tangible asset value | 55.88B | 55.97B | 63.57B | 63.33B | 62.97B | |
Net current asset value | -82.21B | -82.05B | -74.08B | -74.27B | -74.42B | |
Invested capital | 1.43 | 1.44 | 1.16 | 1.15 | 1.16 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 428.5K | 416K | 415.5K | 207.5K | 0 | |
Average inventory | 141.36M | 68.56M | 54.06M | 21.36M | 5.52M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0.02 | 0.05 | 0.17 | 0 | 0 | |
Days of inventory on hand | 3.92 | 7.93 | 17.14 | 4.38 | -116.99 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 3.84K | 1.84K | 514.34 | 0 | 0 | |
Inventory turnover | 22.96 | 11.35 | 5.25 | 20.54 | -0.77 | |
ROE | -0.02 | 0 | -0.02 | 0 | -0.01 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
007630.KS Frequently Asked Questions
What is Polus BioPharm Inc. stock symbol ?
Polus BioPharm Inc. is a US stock and trading under the symbol 007630.KS
What is Polus BioPharm Inc. stock quote today ?
Polus BioPharm Inc. stock price is $45 today.
Is Polus BioPharm Inc. stock public?
Yes, Polus BioPharm Inc. is a publicly traded company.